Pronounced neonatal breast enlargement beyond the first week of life and its regression correlates with serum prolactin levels - a case series

J Pediatr Endocrinol Metab. 2024 Aug 13;37(10):916-923. doi: 10.1515/jpem-2024-0230. Print 2024 Oct 28.

Abstract

Objectives: Mild breast swelling is frequently observed in newborns during the first postnatal week. Breast enlargement is also observed in a minor proportion of infants beyond the first postnatal week, leading to discussions how to deal with it. Our objective was to review a case series of infants with prolonged breast swelling.

Case presentation: We examined five infants with pronounced breast enlargement beyond the first postnatal week and measured human chorionic gonadotropin (HCG), estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), and progesterone (P4) in blood samples and analyzed breast volume by sonographic volume determination in all infants initially and across time. The regression of breast enlargement positively correlated with serum prolactin levels in infants with breast enlargement beyond the first week of life. Complete regression occurred after several weeks and was characterized by normalization of serum prolactin levels.

Conclusions: The present study emphasizes the role of prolactin in neonates with pronounced breast enlargement beyond the first week of life.

Keywords: breast enlargement; infants; prolactin.

MeSH terms

  • Breast* / diagnostic imaging
  • Breast* / growth & development
  • Breast* / pathology
  • Female
  • Humans
  • Hypertrophy / blood
  • Infant
  • Infant, Newborn
  • Luteinizing Hormone / blood
  • Male
  • Prognosis
  • Prolactin* / blood

Substances

  • Luteinizing Hormone
  • Prolactin